Interaction of p53 with mismatched DNA induces proteolytic cleavage with re
lease of a 35-kDa protein fragment from the p53-DNA complexes. The 35-kDa c
leavage product is activated for specific biochemical function(s) and may p
lay a role in the cellular response to DNA damage (Molinari et al (1996) On
cogene 13: 2077-2086; Okorokov et al (1997) EMBO J16: 6008-6017). In the pr
esent study we have asked ii mutants of p53 retain the ability to undergo s
imilar proteolytic cleavage, and compared sequence-specific 'DNA contact' w
ith 'structural' mutants commonly found in human cancer. In addition, a ser
ies of phosphorylation site mutants were generated to investigate the possi
ble effects of phosphorylation/dephosphorylation on the proteolytic cleavag
e of p53. All mutants tested bound to a mismatched DNA target in vitro. Mor
eover, studies in vitro and in vivo indicate that p53 mutants with intact c
onformational structure (as determined by immunoreactivity with PAb246 and
PAb1620) retain the ability to undergo proteolytic cleavage similar, if not
identical, to the wild-type p53 protein. Our results suggest that the capa
city for p53 to bind mismatched DNA is independent of structural conformati
on of the central core domain. Proteolytic cleavage, however, is crucially
dependent upon a wild-type conformation of the protein. (C) 1999 Cancer Res
earch Campaign.